Noveome Biotherapeutics, Inc. — Form D/A

Noveome Biotherapeutics, Inc. of PITTSBURGH, PA, a company, filed a Form D amendment with the SEC on 2019-04-22. The offering totals $15.0M, of which $15.0M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (26)

Showing 25 of 26 people.

NameRoleLocation
Terence GoldenRelated PersonPittsburgh, PA
William GoldenRelated PersonPittsburgh, PA
Robert LangerRelated PersonPittsburgh, PA
John McArthurRelated PersonPittsburgh, PA
Donald WagnerRelated PersonPittsburgh, PA
Patrick WelchRelated PersonPittsburgh, PA
William GoldenDirectorPittsburgh, PA
William GoldenExecutive OfficerPittsburgh, PA
Michael KaufmanDirectorBeachwood, OH
Robert LangerDirectorPittsburgh, PA
Houman HemmatiDirectorBeachwood, OH
Craig NemiroffDirectorBeachwood, OH
Eric KellerDirectorMcLean, VA
Patrick WelchDirectorPittsburgh, PA
Patrick WelchExecutive OfficerPittsburgh, PA
Ronald PoropatichDirectorPittsburgh, PA
Gretchen KraemerExecutive OfficerPittsburgh, PA
Patric WelchDirectorPittsburgh, PA
Patric WelchExecutive OfficerPittsburgh, PA
Terence GoldenDirectorPittsburgh, PA
Donald WagnerDirectorPittsburgh, PA
John McArthurDirectorPittsburgh, PA
A. Clarke AtwellDirectorPITTSBURGH, PA
A. Clarke AtwellExecutive OfficerPITTSBURGH, PA
George SingDirectorPITTSBURGH, PA

Other filings by this issuer (7)

FiledFormOfferingSold
2024-08-08D/A$51.3M$36.2M
2023-08-17D$40.2M$20.7M
2020-10-02D$15.0M$870K
2018-01-24D$15.0M$2.4M
2016-04-14D/A$2.5M$2.2M
2016-01-13D$2.5M$1.7M
2012-07-12D$571K$571K

More